We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TU icon
776
Telus
TU
$15.3B
$921K 0.01%
+49,862
New +$922K
RMD icon
777
ResMed
RMD
$30.7B
$919K 0.01%
7,534
+4,167
+124% +$462K
WHF icon
778
WhiteHorse Finance
WHF
$146M
$916K 0.01%
+66,594
New +$948K
CENTA icon
779
Central Garden & Pet Co Class A
CENTA
$2.44B
$911K 0.01%
+46,179
New +$928K
CORT icon
780
Corcept Therapeutics
CORT
$12B
$907K 0.01%
81,348
-47,787
-37% -$532K
CFR icon
781
Cullen/Frost Bankers
CFR
$10.2B
$906K 0.01%
+9,674
New +$946K
HIBB
782
DELISTED
Hibbett, Inc. Common Stock
HIBB
$906K 0.01%
49,784
-77,256
-61% -$1.62M
UNT
783
DELISTED
UNIT Corporation
UNT
$902K 0.01%
101,404
-17,306
-15% -$201K
HOME
784
DELISTED
At Home Group Inc.
HOME
$899K 0.01%
134,976
+78,735
+140% +$1.39M
PWR icon
785
Quanta Services
PWR
$101B
$895K 0.01%
+23,439
New +$890K
CVI icon
786
CVR Energy
CVI
$3.13B
$891K 0.01%
+17,830
New +$800K
EEX
787
DELISTED
Emerald Holding
EEX
$877K 0.01%
78,668
-36,038
-31% -$449K
QRVO icon
788
Qorvo
QRVO
$8.74B
$870K 0.01%
13,065
-13,561
-51% -$942K
CAKE icon
789
Cheesecake Factory
CAKE
$5.33B
$868K 0.01%
19,851
+8,296
+72% +$388K
UGI icon
790
UGI
UGI
$7.33B
$861K 0.01%
16,124
+5,593
+53% +$298K
VTR icon
791
Ventas
VTR
$47.9B
$858K 0.01%
+12,551
New +$800K
PCG icon
792
PG&E
PCG
$38.5B
$843K 0.01%
+36,765
New +$739K
AOS icon
793
A.O. Smith
AOS
$8.7B
$841K 0.01%
17,817
-14,765
-45% -$724K
VCTR icon
794
Victory Capital Holdings
VCTR
$6.65B
$839K 0.01%
48,783
-10,913
-18% -$180K
TTM
795
DELISTED
Tata Motors Limited
TTM
$839K 0.01%
+71,833
New +$977K
AMN icon
796
AMN Healthcare
AMN
$1.4B
$837K 0.01%
+15,429
New +$783K
VRS
797
DELISTED
Verso Corporation
VRS
$835K 0.01%
43,846
+13,099
+43% +$265K
SYNH
798
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$834K 0.01%
16,323
-40,721
-71% -$1.9M
BAX icon
799
Baxter International
BAX
$14.2B
$829K 0.01%
10,117
-15,998
-61% -$1.24M
WIT icon
800
Wipro
WIT
$20B
$829K 0.01%
+382,710
New +$843K
30 31
32
33 34

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.